全球DNA合成市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

DNA合成市場預計將從2025年的63.9億美元成長到2034年的315.3億美元，2026年至2034年的複合年成長率為19.41%。

由於合成生物學、基因治療、疫苗研發和診斷等領域的應用不斷擴展，全球DNA合成市場正經歷顯著成長。生物技術的進步和對客製化基因序列日益成長的需求是推動市場擴張的主要因素。研究機構、製藥公司和生物技術公司是這項需求成長的主要貢獻者。

關鍵成長要素包括DNA合成成本的降低、自動化技術的進步以及對基因研究的大力投入。基因療法和細胞療法的快速發展催生了對高品質合成DNA的強勁需求。此外，政府和私人對生命科學研究的投資也進一步推動了全球市場的發展。

展望未來，由於酵素合成技術和高通量平台的創新，DNA合成市場預計將快速擴張。處理時間的縮短、準確性的提高以及生物安全措施的加強將推動產業成長。隨著生物技術的不斷發展，DNA合成技術仍將是支撐未來醫療保健和工業生物學的基礎技術。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球DNA合成市場：依服務分類

• 市場分析、洞察與預測
• 寡核苷酸合成
• 基因合成

第5章 全球DNA合成市場：依方法分類

• 市場分析、洞察與預測
• 固相合成
• 基於PCR的酶合成
• 基於晶片的合成

第6章 全球DNA合成市場：依應用分類

• 市場分析、洞察與預測
• 研究與開發
• 診斷
• 治療藥物

第7章 全球DNA合成市場：依最終用途分類

• 市場分析、洞察與預測
• 生物製藥公司
• 學術研究機構
• 受託研究機構

第8章 全球DNA合成市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第9章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第10章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Biomatik Corporation
  • Bioneer Corporation
  • Eton Bioscience Inc
  • Eurofins Scientific SE
  • GenScript Biotech Corporation
  • IBA Lifesciences GmbH
  • Integrated DNA Technologies Inc
  • Kaneka Eurogentec SA
  • LGC Biosearch Technologies
  • OriGene Technologies Inc
  • ProMab Biotechnologies Inc
  • ProteoGenix
  • Quintara Biosciences
  • Synbio Technologies
  • Thermo Fisher Scientific Inc

The DNA Synthesis Market size is expected to reach USD 31.53 Billion in 2034 from USD 6.39 Billion (2025) growing at a CAGR of 19.41% during 2026-2034.

The Global DNA Synthesis Market is witnessing significant growth due to increasing applications in synthetic biology, gene therapy, vaccine development, and diagnostics. Advances in biotechnology and the rising demand for customized genetic sequences are driving the expansion of this market. Research institutions, pharmaceutical companies, and biotech firms are major contributors to its growing demand.

Important growth drivers include declining DNA synthesis costs, improvements in automation technologies, and strong investments in genetic research. The rapid development of gene and cell therapies has created a strong need for high-quality synthetic DNA. Additionally, government funding and private investments in life sciences research are further supporting market development globally.

Looking forward, the DNA synthesis market is expected to expand rapidly with innovations in enzymatic synthesis and high-throughput platforms. Faster turnaround times, improved accuracy, and enhanced biosecurity measures will strengthen industry growth. As biotechnology continues to evolve, DNA synthesis will remain a fundamental technology supporting the future of healthcare and industrial biology.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Service

• Oligonucleotide Synthesis
• Gene Synthesis

By Method

• Solid-phase Synthesis
• PCR-based Enzyme Synthesis
• Chip-based Synthesis

By Application

• Research and Development
• Diagnostics
• Therapeutics

By End-Use

• Biopharmaceutical Companies
• Academic & Research Institutes
• Contract Research Organizations

COMPANIES PROFILED

• Biomatik Corporation, Bioneer Corporation, Eton Bioscience Inc, Eurofins Scientific SE, GenScript Biotech Corporation, IBA Lifesciences GmbH, Integrated DNA Technologies Inc, Kaneka Eurogentec SA, LGC Biosearch Technologies, OriGene Technologies Inc, ProMab Biotechnologies Inc, ProteoGenix, Quintara Biosciences, Synbio Technologies, Thermo Fisher Scientific Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL DNA SYNTHESIS MARKET: BY SERVICE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Service
• 4.2. Oligonucleotide Synthesis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Gene Synthesis Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL DNA SYNTHESIS MARKET: BY METHOD 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Method
• 5.2. Solid-phase Synthesis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. PCR-based Enzyme Synthesis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Chip-based Synthesis Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL DNA SYNTHESIS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Application
• 6.2. Research and Development Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Diagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Therapeutics Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL DNA SYNTHESIS MARKET: BY END-USE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End-use
• 7.2. Biopharmaceutical Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Academic & Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Contract Research Organizations Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL DNA SYNTHESIS MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Service
  • 8.2.2 By Method
  • 8.2.3 By Application
  • 8.2.4 By End-use
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Service
  • 8.3.2 By Method
  • 8.3.3 By Application
  • 8.3.4 By End-use
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Service
  • 8.4.2 By Method
  • 8.4.3 By Application
  • 8.4.4 By End-use
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Service
  • 8.5.2 By Method
  • 8.5.3 By Application
  • 8.5.4 By End-use
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Service
  • 8.6.2 By Method
  • 8.6.3 By Application
  • 8.6.4 By End-use
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL DNA SYNTHESIS INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Biomatik Corporation
  • 10.2.2 Bioneer Corporation
  • 10.2.3 Eton Bioscience Inc
  • 10.2.4 Eurofins Scientific SE
  • 10.2.5 GenScript Biotech Corporation
  • 10.2.6 IBA Lifesciences GmbH
  • 10.2.7 Integrated DNA Technologies Inc
  • 10.2.8 Kaneka Eurogentec S.A
  • 10.2.9 LGC Biosearch Technologies
  • 10.2.10 OriGene Technologies Inc
  • 10.2.11 ProMab Biotechnologies Inc
  • 10.2.12 ProteoGenix
  • 10.2.13 Quintara Biosciences
  • 10.2.14 Synbio Technologies
  • 10.2.15 Thermo Fisher Scientific Inc